Methods This retrospective, database study used Optums de-identified Clinformatics Data Mart Database to identify glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment-nave adult patients with type 2 diabetes (T2D) initiating semaglutide QW, dulaglutide, liraglutide, or exenatide QW between January 1, 2018 and April 30, 2019
Muscle injection can affect absorption and cause more pain
Aim for at least 0.7 to 1 gram per pound of lean body mass daily
The first month often brings 13 pounds of weight loss as your body adjusts to reduced calorie intake from decreased hunger
The guideline states that insufficient literature was identified to constitute an evidence base for diagnosis of IC/BPS in clinical practice
#GLP1 receptor agonists are linked to a modest rise in biliary events in #Diabetes More gallstones/cholecystitis/cholecystectomy at 3 years No significant increase in pancreatitis or ERCP Absolute event rates remained low #OpenAccess bit.ly/4x0N5B0 #GLP1 receptor agonists are linked to a modest rise in biliary events in #Diabetes More gallstones/cholecystitis/cholecystectomy at 3 years No significant increase in pancreatitis or ERCP Absolute event rates remained low #OpenAccess bit.ly/4x0N5B0 This Post is unavailable
